Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diabetes

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 81 articles:
HTML format
Text format



Single Articles


    March 2017

  1. Metformin for Prediabetes.
    JAMA. 2017;317:1171.
    PubMed     Text format    


  2. MICHA R, Penalvo JL, Cudhea F, Imamura F, et al
    Association Between Dietary Factors and Mortality From Heart Disease, Stroke, and Type 2 Diabetes in the United States.
    JAMA. 2017;317:912-924.
    PubMed     Text format     Abstract available


  3. REUSCH JE, Manson JE
    Management of Type 2 Diabetes in 2017: Getting to Goal.
    JAMA. 2017 Mar 1. doi: 10.1001/jama.2017.0241.
    PubMed     Text format    


    February 2017
  4. DABELEA D, Stafford JM, Mayer-Davis EJ, D'Agostino R Jr, et al
    Association of Type 1 Diabetes vs Type 2 Diabetes Diagnosed During Childhood and Adolescence With Complications During Teenage Years and Young Adulthood.
    JAMA. 2017;317:825-835.
    PubMed     Text format     Abstract available


  5. EMDIN CA, Khera AV, Natarajan P, Klarin D, et al
    Genetic Association of Waist-to-Hip Ratio With Cardiometabolic Traits, Type 2 Diabetes, and Coronary Heart Disease.
    JAMA. 2017;317:626-634.
    PubMed     Text format     Abstract available


  6. ABBASI J
    Unveiling the "Magic" of Diabetes Remission After Weight-Loss Surgery.
    JAMA. 2017;317:571-574.
    PubMed     Text format    


  7. BRITO JP, Montori VM, Davis AM
    Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations.
    JAMA. 2017;317:635-636.
    PubMed     Text format    


  8. XIANG AH
    Association of Maternal Diabetes With Autism in Offspring.
    JAMA. 2017;317:537-538.
    PubMed     Text format    


  9. HAMPTON T
    Drug Under Study for Diabetes a Potential Parkinson Therapy.
    JAMA. 2017;317:465.
    PubMed     Text format    


  10. LACY ME, Wellenius GA, Sumner AE, Correa A, et al
    Association of Sickle Cell Trait With Hemoglobin A1c in African Americans.
    JAMA. 2017;317:507-515.
    PubMed     Text format     Abstract available


    January 2017
  11. LIPSKA KJ, Krumholz HM
    Is Hemoglobin A1c the Right Outcome for Studies of Diabetes?
    JAMA. 2017 Jan 26. doi: 10.1001/jama.2017.0029.
    PubMed     Text format    


  12. LIND M, Polonsky W, Hirsch IB, Heise T, et al
    Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
    JAMA. 2017;317:379-387.
    PubMed     Text format     Abstract available


  13. BECK RW, Riddlesworth T, Ruedy K, Ahmann A, et al
    Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    JAMA. 2017;317:371-378.
    PubMed     Text format     Abstract available


  14. DAVIDSON MB
    Continuous Glucose Monitoring in Patients With Type 1 Diabetes Taking Insulin Injections.
    JAMA. 2017;317:363-364.
    PubMed     Text format    


  15. BRAGG F, Holmes MV, Iona A, Guo Y, et al
    Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China.
    JAMA. 2017;317:280-289.
    PubMed     Text format     Abstract available


  16. VOELKER R
    Diabetes Drug Gains New Indication.
    JAMA. 2017;317:247.
    PubMed     Text format    


  17. CHAN M
    China's Burgeoning Epidemic of Diabetes-Associated Mortality.
    JAMA. 2017;317:264-266.
    PubMed     Text format    


    December 2016
  18. KOMAROFF AL
    The Microbiome and Risk for Obesity and Diabetes.
    JAMA. 2016 Dec 22. doi: 10.1001/jama.2016.20099.
    PubMed     Text format    


  19. ABBASI J
    NIH Charts a Path for Nutrition Science.
    JAMA. 2016 Dec 14. doi: 10.1001/jama.2016.18217.
    PubMed     Text format    


  20. MARGULIES KB, McNulty SE, Cappola TP
    Lack of Benefit for Liraglutide in Heart Failure-Reply.
    JAMA. 2016;316:2429-2430.
    PubMed     Text format    


  21. CARBONE S, Arena R, Abbate A
    Lack of Benefit for Liraglutide in Heart Failure.
    JAMA. 2016;316:2429.
    PubMed     Text format    


    November 2016
  22. WONG TY, Bressler NM
    Artificial Intelligence With Deep Learning Technology Looks Into Diabetic Retinopathy Screening.
    JAMA. 2016 Nov 29. doi: 10.1001/jama.2016.17563.
    PubMed     Text format    


  23. GULSHAN V, Peng L, Coram M, Stumpe MC, et al
    Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs.
    JAMA. 2016 Nov 29. doi: 10.1001/jama.2016.17216.
    PubMed     Text format     Abstract available


    October 2016
  24. SLOMSKI A
    Eating Oily Fish May Protect Against Diabetic Retinopathy.
    JAMA. 2016;316:1637.
    PubMed     Text format    


  25. SCHILLINGER D, Jacobson MF
    Science and Public Health on Trial: Warning Notices on Advertisements for Sugary Drinks.
    JAMA. 2016;316:1545-1546.
    PubMed     Text format    


  26. LOTTA LA, Sharp SJ, Burgess S, Perry JR, et al
    Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis.
    JAMA. 2016;316:1383-1391.
    PubMed     Text format     Abstract available


    September 2016
  27. SLOMSKI A
    Telemonitoring Helps Keep Diabetes Under Control.
    JAMA. 2016;316:1250.
    PubMed     Text format    


  28. VOELKER R
    Injectable Diabetes Drug Approved.
    JAMA. 2016;316:1142.
    PubMed     Text format    


  29. BERGENSTAL RM, Garg S, Weinzimer SA, Buckingham BA, et al
    Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes.
    JAMA. 2016 Sep 15. doi: 10.1001/jama.2016.11708.
    PubMed     Text format    


    August 2016
  30. HALL M, Dondo TB, Yan AT, Goodman SG, et al
    Association of Clinical Factors and Therapeutic Strategies With Improvements in Survival Following Non-ST-Elevation Myocardial Infarction, 2003-2013.
    JAMA. 2016 Aug 30. doi: 10.1001/jama.2016.10766.
    PubMed     Text format     Abstract available


  31. BEYERLEIN A, Donnachie E, Ziegler AG
    Association of Infection in Early Life and Risk of Developing Type 1 Diabetes--Reply.
    JAMA. 2016;316:883.
    PubMed     Text format    


  32. UZOIGWE OF
    Association of Infection in Early Life and Risk of Developing Type 1 Diabetes.
    JAMA. 2016;316:882-3.
    PubMed     Text format    


  33. RAHMOUNE H, Boutrid N, Bioud B
    Association of Infection in Early Life and Risk of Developing Type 1 Diabetes.
    JAMA. 2016;316:882.
    PubMed     Text format    


  34. REISS-BRENNAN B, Brunisholz KD, Dredge C, Briot P, et al
    Association of Integrated Team-Based Care With Health Care Quality, Utilization, and Cost.
    JAMA. 2016;316:826-34.
    PubMed     Text format     Abstract available


  35. AFKARIAN M, Zelnick LR, Hall YN, Heagerty PJ, et al
    Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014.
    JAMA. 2016;316:602-10.
    PubMed     Text format     Abstract available


  36. HUA X, Herman WH, Clarke P
    Cost of Antihyperglycemic Medications in the United States--Reply.
    JAMA. 2016;316:665-6.
    PubMed     Text format    


  37. ALATORRE C, Schultz EH, Nelson DR
    Cost of Antihyperglycemic Medications in the United States.
    JAMA. 2016;316:665.
    PubMed     Text format    


  38. CHATTERJEE S
    Laboratory Testing in the Setting of Diabetic Scleredema--Reply.
    JAMA. 2016;316:543.
    PubMed     Text format    


  39. ALTER D
    Laboratory Testing in the Setting of Diabetic Scleredema.
    JAMA. 2016;316:542.
    PubMed     Text format    


  40. MARGULIES KB, Hernandez AF, Redfield MM, Givertz MM, et al
    Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.
    JAMA. 2016;316:500-8.
    PubMed     Text format     Abstract available


    July 2016
  41. LIPSKA KJ
    JAMA PATIENT PAGE. Diabetes in Older People.
    JAMA. 2016;316:362.
    PubMed     Text format    


  42. MENKE A, Casagrande S, Cowie CC
    Prevalence of Diabetes in Adolescents Aged 12 to 19 Years in the United States, 2005-2014.
    JAMA. 2016;316:344-5.
    PubMed     Text format    


  43. PALMER SC, Mavridis D, Nicolucci A, Johnson DW, et al
    Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes: A Meta-analysis.
    JAMA. 2016;316:313-24.
    PubMed     Text format     Abstract available


    May 2016
  44. CREATORE MI, Glazier RH, Moineddin R, Fazli GS, et al
    Association of Neighborhood Walkability With Change in Overweight, Obesity, and Diabetes.
    JAMA. 2016;315:2211-20.
    PubMed     Text format     Abstract available


  45. RUNDLE AG, Heymsfield SB
    Can Walkable Urban Design Play a Role in Reducing the Incidence of Obesity-Related Conditions?
    JAMA. 2016;315:2175-7.
    PubMed     Text format    


  46. BEYERLEIN A, Donnachie E, Jergens S, Ziegler AG, et al
    Infections in Early Life and Development of Type 1 Diabetes.
    JAMA. 2016;315:1899-901.
    PubMed     Text format    


    April 2016
  47. KLEIN R, Klein BE
    Body Fat Distribution and Diabetic Retinopathy in People With Type 2 Diabetes.
    JAMA. 2016;315:1778-9.
    PubMed     Text format    


  48. LEE JM, Hirschfeld E, Wedding J
    A Patient-Designed Do-It-Yourself Mobile Technology System for Diabetes: Promise and Challenges for a New Era in Medicine.
    JAMA. 2016;315:1447-8.
    PubMed     Text format    


  49. HUA X, Carvalho N, Tew M, Huang ES, et al
    Expenditures and Prices of Antihyperglycemic Medications in the United States: 2002-2013.
    JAMA. 2016;315:1400-2.
    PubMed     Text format    


    March 2016
  50. YEH RW, Secemsky EA, Kereiakes DJ, Normand ST, et al
    Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.
    JAMA. 2016 Mar 29. doi: 10.1001/jama.2016.3775.
    PubMed     Text format     Abstract available


  51. ARTERBURN D, McCulloch D
    Bariatric Surgery for Type 2 Diabetes: Getting Closer to the Long-term Goal.
    JAMA. 2016;315:1276-7.
    PubMed     Text format    


  52. CHATTERJEE S
    Neck Pain, Stiffness, and Periorbital Edema in a Man With Diabetes.
    JAMA. 2016;315:1159-60.
    PubMed     Text format    


  53. ROUGH K, Bateman BT, Patorno E, Desai RJ, et al
    Suppression of Substance Abuse Claims in Medicaid Data and Rates of Diagnoses for Non-Substance Abuse Conditions.
    JAMA. 2016;315:1164-6.
    PubMed     Text format    


  54. TYRRELL J, Richmond RC, Palmer TM, Feenstra B, et al
    Genetic Evidence for Causal Relationships Between Maternal Obesity-Related Traits and Birth Weight.
    JAMA. 2016;315:1129-40.
    PubMed     Text format     Abstract available


  55. BLENNER SR, Kollmer M, Rouse AJ, Daneshvar N, et al
    Privacy Policies of Android Diabetes Apps and Sharing of Health Information.
    JAMA. 2016;315:1051-2.
    PubMed     Text format    


  56. LIPSKA KJ, Krumholz H, Soones T, Lee SJ, et al
    Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes.
    JAMA. 2016;315:1034-45.
    PubMed     Text format     Abstract available


  57. LINGVAY I, Manghi FP, Garcia-Hernandez P, Norwood P, et al
    Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes: The DUAL V Randomized Clinical Trial.
    JAMA. 2016;315:898-907.
    PubMed     Text format     Abstract available


    February 2016
  58. MENKE A, Casagrande S, Cowie CC
    US Trends for Diabetes Prevalence Among Adults--Reply.
    JAMA. 2016;315:705-6.
    PubMed     Text format    


  59. MAGLIANO DJ, Zimmet P, Shaw J
    US Trends for Diabetes Prevalence Among Adults.
    JAMA. 2016;315:705.
    PubMed     Text format    


  60. LAITEERAPONG N, Cifu AS
    Screening for Prediabetes and Type 2 Diabetes Mellitus.
    JAMA. 2016;315:697-8.
    PubMed     Text format    


  61. O'KEEFFE DT, Maraka S, Rizza RA
    HbA1c in the Evaluation of Diabetes Mellitus.
    JAMA. 2016;315:605-6.
    PubMed     Text format    


  62. NEWGARD CD, Lewis RJ
    Accounting for Missing Data in Clinical Research--Reply.
    JAMA. 2016;315:518.
    PubMed     Text format    


  63. STEVENS JR, Suyundikov A, Slattery ML
    Accounting for Missing Data in Clinical Research.
    JAMA. 2016;315:517-8.
    PubMed     Text format    


    January 2016
  64. BAKRIS GL, Nowack C
    Finerenone for Albuminuria in Patients With Diabetic Nephropathy--Reply.
    JAMA. 2016;315:306.
    PubMed     Text format    


  65. FENG Y, Zeng X, Fu P
    Finerenone for Albuminuria in Patients With Diabetic Nephropathy.
    JAMA. 2016;315:305-6.
    PubMed     Text format    


  66. CALLAGHAN BC, Burke JF, Feldman EL
    Electrodiagnostic Tests in Polyneuropathy and Radiculopathy.
    JAMA. 2016;315:297-8.
    PubMed     Text format    


    December 2015
  67. SLOMSKI A
    Diabetics May Benefit From Moderate Wine Consumption.
    JAMA. 2015;314:2608.
    PubMed     Text format    


  68. FERRARA A, Lewis JD, Habel LA
    Pioglitazone Use and Risk of Bladder Cancer-Reply.
    JAMA. 2015;314:2568-2569.
    PubMed     Text format    


  69. DAVIES BJ
    Pioglitazone Use and Risk of Bladder Cancer.
    JAMA. 2015;314:2568.
    PubMed     Text format    


  70. SINGH S, Suchard MA
    Pioglitazone Use and Risk of Bladder Cancer.
    JAMA. 2015;314:2567-2568.
    PubMed     Text format    


  71. HUANG W, Mirza RG, Molitch ME
    What Does This Retina Examination Show?
    JAMA. 2015;314:2555-6.
    PubMed     Text format    


  72. LIBMAN IM, Miller KM, DiMeglio LA, Bethin KE, et al
    Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial.
    JAMA. 2015;314:2241-50.
    PubMed     Text format     Abstract available


  73. BLACK M, Bhattacharya S, Philip S, Norman JE, et al
    Planned Cesarean Delivery at Term and Adverse Outcomes in Childhood Health.
    JAMA. 2015;314:2271-9.
    PubMed     Text format     Abstract available


    November 2015
  74. RAZMARIA AA
    JAMA PATIENT PAGE. Diabetic Neuropathy.
    JAMA. 2015;314:2202.
    PubMed     Text format    



  75. VEGF Inhibitors for AMD and Diabetic Macular Edema.
    JAMA. 2015;314:2184-2185.
    PubMed     Text format    


  76. JACOB JA
    New Type 2 Diabetes Portal Open to Researchers and Public.
    JAMA. 2015;314:2121.
    PubMed     Text format    


  77. CALLAGHAN BC, Price RS, Feldman EL
    Distal Symmetric Polyneuropathy: A Review.
    JAMA. 2015;314:2172-81.
    PubMed     Text format     Abstract available


  78. GROSS JG, Glassman AR, Jampol LM, Inusah S, et al
    Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
    JAMA. 2015 Nov 13:1-11. doi: 10.1001/jama.2015.15217.
    PubMed     Text format     Abstract available


  79. OLSEN TW
    Anti-VEGF Pharmacotherapy as an Alternative to Panretinal Laser Photocoagulation for Proliferative Diabetic Retinopathy.
    JAMA. 2015 Nov 13:1-3. doi: 10.1001/jama.2015.15409.
    PubMed     Text format    


  80. VIJAN S, Fagerlin A
    Diabetes Risk Assessment and Glycemic Control.
    JAMA. 2015;314:1861-2.
    PubMed     Text format    


    October 2015
  81. MA J, Ward EM, Siegel RL, Jemal A, et al
    Temporal Trends in Mortality in the United States, 1969-2013.
    JAMA. 2015;314:1731-9.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: